Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-098454
Filing Date
2026-03-09
Accepted
2026-03-09 16:03:57
Documents
109
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K alxo-20251231.htm   iXBRL 10-K 4400128
2 EX-10.10 alxo-ex10_10.htm EX-10.10 67801
3 EX-10.12 alxo-ex10_12.htm EX-10.12 124261
4 EX-23.1 alxo-ex23_1.htm EX-23.1 3666
5 EX-31.1 alxo-ex31_1.htm EX-31.1 18260
6 EX-31.2 alxo-ex31_2.htm EX-31.2 18492
7 EX-32.1 alxo-ex32_1.htm EX-32.1 10314
8 EX-32.2 alxo-ex32_2.htm EX-32.2 10338
9 GRAPHIC img166414910_0.jpg GRAPHIC 321124
10 GRAPHIC img166414910_1.jpg GRAPHIC 174233
11 GRAPHIC img166414910_2.jpg GRAPHIC 91502
12 GRAPHIC img166414910_3.jpg GRAPHIC 205111
13 GRAPHIC img166414910_4.jpg GRAPHIC 434779
14 GRAPHIC img166414910_5.jpg GRAPHIC 111239
15 GRAPHIC img166414910_6.jpg GRAPHIC 149874
16 GRAPHIC img166414910_7.jpg GRAPHIC 303161
17 GRAPHIC img166414910_8.jpg GRAPHIC 491559
18 GRAPHIC img166414910_9.jpg GRAPHIC 461178
19 GRAPHIC img166414910_10.jpg GRAPHIC 213285
20 GRAPHIC img166414910_11.jpg GRAPHIC 95594
21 GRAPHIC img166414910_12.jpg GRAPHIC 204882
22 GRAPHIC img166414910_13.jpg GRAPHIC 144973
23 GRAPHIC img166414910_14.jpg GRAPHIC 405320
24 GRAPHIC img166414910_15.jpg GRAPHIC 450282
  Complete submission text file 0001193125-26-098454.txt   27666827

Data Files

Seq Description Document Type Size
25 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alxo-20251231.xsd EX-101.SCH 1801276
112 EXTRACTED XBRL INSTANCE DOCUMENT alxo-20251231_htm.xml XML 3334180
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

EIN.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39386 | Film No.: 26734837
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)